Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

B5, a new B cell-restricted activation antigen.

A S Freedman, A W Boyd, K C Anderson

    Journal of Immunology (Baltimore, Md. : 1950)
    |April 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of video vector analysis of ankle foot orthoses in children with physical disability: A 10-year clinical review.

    Gait & posture·2024
    Same author

    Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways.

    Molecular neurobiology·2018
    Same author

    Decreased signalling of EphA4 improves functional performance and motor neuron survival in the SOD1<sup>G93A</sup> ALS mouse model.

    Scientific reports·2018
    Same author

    Pityriasis rubra pilaris-like erythroderma secondary to phosphoinositide 3-kinase inhibition.

    Clinical and experimental dermatology·2018
    Same author

    EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.

    Leukemia·2016
    Same author

    Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant.

    British journal of cancer·2015

    Researchers identified a new human B cell antigen, B5, which appears only on activated B cells. This discovery offers a new tool for studying early B cell activation events.

    Area of Science:

    • Immunology
    • Cell Biology

    Background:

    • B cell activation involves complex molecular changes.
    • Identifying specific activation markers is crucial for understanding immune responses.
    • Previous markers may not fully capture early B cell activation dynamics.

    Purpose of the Study:

    • To characterize a novel human B cell-restricted activation antigen, designated B5.
    • To determine the expression pattern of B5 on different cell types and under various activation conditions.

    Main Methods:

    • Utilized a monoclonal antibody specific to the B5 antigen.
    • Analyzed B5 expression on peripheral blood and splenic B cells following stimulation.
    • Assessed B5 expression on resting and activated B, T, and myeloid cells.
    • Examined B5 expression on lymphoblastoid cell lines and various neoplasms.

    Related Experiment Videos

    Main Results:

    • B5 is detected on human B cells after 1 day of stimulation with diverse stimuli (anti-Ig, protein A, EBV, PWM).
    • B5 is not expressed on resting B, T, or myeloid cells.
    • B5 is absent on activated T cells and monocytes.
    • B5 is expressed on some B cell lines and neoplasms but not on T or myeloid leukemias/lymphomas.

    Conclusions:

    • B5 represents a novel, B cell-restricted activation antigen.
    • Its unique molecular weight and expression pattern distinguish it from known B cell activation antigens.
    • B5 holds potential utility for investigating early human B cell activation processes.